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Fat grafting is an established clinical intervention to promote tissue repair. The role of the
fat's extracellular matrix (ECM) in regeneration is largely neglected. We investigated
in vitro the use of human adipose tissue‐derived ECM hydrogels as release platform
for factors secreted by adipose‐derived stromal cells (ASCs). Lipoaspirates from nondia-
betic and diabetic donors were decellularized. Finely powdered acellular ECM was
evaluated for cell remainders and DNA content. Acellular ECM was digested, and
hydrogels were formed at 37°C and their viscoelastic relaxation properties investigated.
Release of ASC‐released factors from hydrogels was immune assessed, and bio‐activity
was determined by fibroblast proliferation and migration and endothelial angiogenesis.
Acellular ECM contained no detectable cell remainders and negligible DNA contents.
Viscoelastic relaxation measurements yielded no data for diabetic‐derived hydrogels
due to gel instability. Hydrogels released several ASC‐released factors concurrently in
a sustained fashion. Functionally, released factors stimulated fibroblast proliferation
and migration as well as angiogenesis. No difference between nondiabetic and diabetic
hydrogels in release of factors was measured. Adipose ECM hydrogels incubated with
released factors by ASC are a promising new therapeutic modality to promote several
important wound healing‐related processes by releasing factors in a controlled way.
KEYWORDS
acellular matrix, decellularization, growth factors, hydrogel, mesenchymal stem cells,
wound healing1 | INTRODUCTION
Autologous fat grafting has been widely investigated and used for soft‐
tissue defects and regenerative purposes such as the treatment of open
wounds as well as antiscarring treatments (Han, Kim, & Kim, 2010; Jas-
pers et al., 2017; Negenborn, Groen, Smit, Niessen, & Mullender, 2016;
Stasch et al., 2015). Diabetes is associated with dysfunctional wound
healing and occurrence of nonhealing ulcers. A significant proportion- - - - - - - - - - - - - - - - - - - - - - - - - -
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and Regenerative Medicine Publof diabetics does not respond to revascularization therapies, which reg-
ularly results in amputation of the affected limb. Few noncontrolled
clinical trials and case reports have shown that diabetic wound healing
is augmented by lipografting (Cervelli et al., 2010; Han et al., 2010;
Stasch et al., 2015; Vicenti et al., 2017). One of the key components
of this regenerative potential of adipose tissue that dictates tissue
regeneration is the stromal vascular fraction (SVF), which is rich in adi-
pose tissue‐derived stromal cells (ASCs). In the SVF, ASCs are present- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
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974 VAN DONGEN ET AL.as pericytes or periadventital vascular cells (Corselli et al., 2012; Lin
et al., 2008). The clinical efficacy of SVF is often ascribed to these res-
ident ASC or other precursor cells, but definitive proof still lacks.
Another important but neglected contributor to regeneration is the
extracellular matrix (ECM), which provides the tissue architecture and
structural support as well as key biochemical signalling cues. The role
of ECM in tissue regeneration is but poorly studied, if at all. ASCs
secrete a plethora of growth factors, cytokines, lipid‐based mediators,
and matrix molecules such as structural components and matrix
metalloproteases (MMPs) that remodel ECM. For instance, MMPs can
degrade the excessively deposited ECM by myofibroblasts in scars,
whereas vascular endothelial growth factors (VEGFs) and fibroblast
growth factors (FGFs) promote wound healing (Spiekman et al., 2014;
Spiekman et al., 2017). The ECM in SVF supports the proliferation
and survival as well as differentiation of cells by binding of their
surface‐expressed integrins to ECM molecules. Moreover, paracrine
factors bind and are retained by proteoglycans and glycoaminoglycans
of ECM. In this way, ECM stores paracrine factors and functions as a
physiological controlled “on‐demand” release system (Mescher, 2010;
van Dongen, Stevens, Harmsen & van der Lei, 2017).
Concentration of the SVF of adipose tissue, that is, to get rid it of the
large amounts of adipocytes and thereby reducing volume, might
augment the clinical observed regenerative potential compared with
standard autologous fat grafting. To concentrate SVF, the SVF can be
isolated enzymatically or mechanically (van Dongen, Tuin, et al., 2017).
Enzymatic isolation destructs the ECM and its interaction with cells and
thus yields a suspension of single SVF cells (cellular SVF or cSVF). Via
centrifugation, adipocytes are readily removed with enzymatic isolation
(van Dongen, Tuin, et al., 2017). When a nonenzymatic isolation proce-
dure is used, adipocytes are mechanically destructed and the ECM is still
intact as are its interactionswith bound cells, and it also acts for sustained
release of bound factors (tissue‐like SVF or tSVF) (van Dongen, Stevens
et al., 2017; van Dongen, Tuin, et al., 2017). Therefore, we anticipate a
nonenzymatically obtained SVF to have a higher therapeutic benefit than
enzymatic SVF or unprocessed lipografts.
Systemic, often chronic, diseases such as diabetes mellitus (DM)
impact the clinical efficacy of autologous SVF injections. For DM, long‐
term hyperglycaemic exposure of ASC and ECM influences their biological
properties (Haucke, Navarrete‐Santos, Simm, Silber, & Hofmann, 2014;
Serban et al., 2015; Voziyan, Brown, Chetyrkin, & Hudson, 2014). High
levels of glucose impair the regenerative function of ASC by intracellular
reactive oxygen species accumulation (Peng et al., 2017). Reactive oxygen
species inhibits the proliferation and proangiogenic capacities of ASC,
which are important processes in wound healing (Peng et al., 2017). Fur-
thermore, high levels of glucose and their glycolytic products such as
methylglyoxal result in glycation of proteins. These so‐called advanced
glycation end products (AGEs) bind to a receptor of AGE (RAGE) that is
expressed by virtually all tissue cells and causes proinflammatory activa-
tion. Inflammation is relevant for wound repair, but increased chronic
inflammation acts adverse and results in decreased vascularization and tis-
sue necrosis as observed in diabetic ulcers. Glycation affects ECM mole-
cules rather than circulating proteins due to their slow turnover, that is,
long half‐life (Verzijl et al., 2000). Elevated AGEs damage ECMpotentially in three different critical sites: compromised cellular binding
site in the ECM, which inhibits cell adhesion, survival, and proliferation.
Second, molecular sites in the ECM that are involved in turnover (both
proteolytic degradation and cross linking) may be affected, which may
result in adverse ECM remodelling, accumulation, changes in mechanical
features, and associated changes of biological responses of bound tissue
cells (Mott et al., 1997; Pozzi et al., 2009; Voziyan et al., 2014). Affected
subunits of ECM molecules lead to more cross links between proteins
and thus an unwanted higher stability and stiffness of ECM proteins
(Voziyan et al., 2014). In soft tissues, increased stiffness promotes fibrotic
processes in a feed‐forward looped fashion.
For those reasons, nondiabetic SVF is likely to be more suitable than
diabetic SVF as treatment for, for example, wound healing of diabetic
ulcers in diabetic patients. This would, however, implicate an allogeneic
tissue transplantation, which will result in an immunological rejection of
the administrated SVF.We surmised that the SVF's biological activity is
primarily contained within the ECM and its bound paracrine factors in
which parenchymal and stromal cells no more than serve to continu-
ously replenish this biological entity. In particular, for short(er) term
applications such as wound healing, ECM loaded with paracrine factors
might show therapeutic efficacy. ECM can be obtained by
decellularization of (adipose) tissue. Literature is littered with a host
of decellullarization protocols that often dictate the use of detergents
such as sodium dodecyl sulphate (SDS) as well as acids and bases to
remove cellular constituents. This procedure not only removes all cell
types but also the paracrine factors (Crapo, Gilbert, & Badylak, 2011).
A decellularized ECM that is devoid of cells and paracrine factors is of
reduced clinical value compared with mechanically derived SVF in
which both ECM and paracrine factors are retained. Therefore,
recharging of ECM with factors, for example, released from cultured
ASC might restore a comparable clinical effect as mechanically derived
SVF while preserving the option for interpatient administration.
In this study, we interrogated uptake and release of ASC‐released
paracrine factors by human adipose tissue‐derived ECM hydrogels
in vitro. The prepared adipose ECM hydrogels were first incubated
with factors released by ASC, that is, conditioned culture medium
and subsequently studied for wound healing purposes. Additionally,
structural differences between diabetic and nondiabetic ECM regard-
ing binding of factors were investigated.2 | MATERIAL AND METHODS
2.1 | Processing and decellularization of adipose
tissue
Adipose tissue was harvested from the abdomen of nondiabetic (n = 5)
and diabetic (n = 5) patients during regular liposuction procedures and
processed anonymously using the FAT procedure, as previously
described by van Dongen, Stevens, Parvizi, van der Lei, and Harmsen
(2016). Informed consent was obtained according to the local ethical
committee of the University Medical Center of Groningen. Briefly,
50‐ml tubes containing lipoaspirate were centrifuged at 960 × g at
VAN DONGEN ET AL. 975room temperature (RT) for 2.5 min. Next, 10 ml of centrifuged adipose
tissue was pushed forward and back 30 times through a Luer‐to‐Luer
connector with three holes of 1.4 mm. The fragmented adipose tissue
was again centrifuged at 960 × g at RT for 2.5 min. This procedure
resulted in 1 ml of tSVF, which was then decellularized, as previously
described by Roehm, Hornberger, and Madihally (2016). Briefly,
10 ml of tSVF was mixed with 30 ml of a 50% ethanol/water mixture
and frozen at −80°C and thawed at RT in 30 min for four cycles. Then
tSVF was incubated in 0.05% trypsin/0.05‐mM ethylenediaminetetra-
acetic acid (EDTA; 1:1 v/v) for 1.5 hr at 37°C. Afterwards, samples
were sonicated (70 W) in 0.5% SDS at 46°C for 20 min. Samples were
then lyophilized and immersed in xylene (1:10 w/v) for 17 min. Next,
samples were washed with 96% ethanol and incubated in DNAse solu-
tion (LS002007, Worthington; containing a final concentration of
30 μg/ml of DNAse in 1.3 mM of MgSO4 and 2 mM of CaCl2) for
24 hr. Finally, samples (acellular matrix) were lyophilized again and
homogenized with the use of an UltraTurrax fragmer (PM Tamson
Instruments) and stored at −80°C before used in experiments.2.2 | Histological characterization of acellular
adipose matrix
One‐time centrifuged adipose tissue and tSVF (controls) as well as
acellular matrix of nondiabetic (NAM) and diabetic patients (DAM;
n = 3) were formalin fixed and embedded in paraffin. Four‐micrometre
thickness sections were cut, deparaffinized, and then incubated over-
night with 0.1 M of Tris/HCL buffer (pH 9.0) at 80°C and stained with
antibody against Perilipin A (1:200, Abcam) to visualize adipocytes as
previously described (van Dongen, Stevens, Parvizi, van der Lei, &
Harmsen, 2016). Samples were visualized under a light microscope
(Leica Microsystems, DM IL). A Masson's trichrome staining and
haematoxylin and eosin (H&E) staining were performed on
deparaffinized 4 μm of slides. Then samples were mounted and visual-
ized under a light microscope (Leica Microsystems, DM IL).2.3 | DNA content measurement
NAM and DAM samples (n = 3) were used to assess presence of DNA.
A solution containing 5 μl of proteinase K (2 U/mg; Sigma Aldrich,
3115828001), 50 μl of 10% SDS, and 500 μl of SE buffer (75 mM of
NaCl, 25 mM of EDTA, and pH 8.0) was added to 10 mg of acellular
matrix. Solutions were mixed gently and incubated overnight at
55°C. Then 6 M of NaCl and chloroform was added, and samples were
thoroughly mixed with the use of a top‐over‐top rotator for 30 min.
Samples were centrifuged at 650 × g at 20°C for 10 min. Next, super-
natant was taken and mixed with ice‐cold isopropanol. Samples were
centrifuged at 18,000 × g at 4°C for 5 min. Then supernatant was
discarded, and pellet was washed with 70% ethanol. Afterwards, pellet
was dissolved in TE buffer (containing 10 mM of Tris, 0.1 mM of
EDTA, and pH 8.0). DNA was quantified with the use of a Nanodrop
metre. Additionally, a DAPI/phosphate‐buffered saline (PBS) stainingwas used to stain nuclei. Samples were visualized under a fluorescence
microscope (Leica Microsystems, DM IL).2.4 | Sulphated glycosaminoglycans measurement
The concentration of sulphated glycosaminoglycans (sGAG) was mea-
sured with the use of a 1,9‐dimethylmethylene blue assay according
to the protocol of Farndale, Sayers, and Barrett (Farndale, Sayers, &
Barrett, 1982). NAM andDAM samples (n = 3) were digested in 1% pro-
teinase K/SE solution at 55°C for 24 hr. As a control, a standard solution
of 10 μg/ml of chondroitin sulphate C (#C4384‐250 mg, Sigma‐Aldrich,
St. Louis, MO) was used. After the addition of the 1,9‐dimethyl-
methylene blue staining solution, extinction was measured at 525 and
595 nm. Additionally, an Alcian blue staining was used to visualize the
total amount of glycosaminoglycans in nondiabetic and diabetic adipose
tissue as well as tSVF and NAM and DAM samples. Samples were visu-
alized under a light microscope (Leica Microsystems, DM IL).2.5 | Cell isolation, characterization, and collection of
conditioned medium of ASCs
Adipose tissue was harvested by normal liposuction procedures from
healthy donors (n = 3) used for cell isolation. Briefly, samples were
washed with PBS three times. Then 0.1% collagenase A/1% bovine
serum albumin in PBS was added as dissociation medium. The samples
with 0.1% collagenase A/bovine serum albumin in PBS were then stirred
in a water bath at 37°C for 1.5 hr. Next, cells were placed in lysis buffer
on ice for 5 min to disrupt all erythrocytes. Cells were then centrifuged
and cultured at 37°C at 5% CO2 in humidified incubator in Dulbecco's
Modified Eagle's Medium (DMEM; BioWhittaker Walkersville, MD:
10% fetal bovine serum [FBS], 1% L‐glutamine [L‐Glut], and 1%
penicillin/streptomycin [P/S]). Medium was refreshed twice a week.
After culture, cells were characterized for ASC characteristics. Cells were
characterized based on CD marker surface expression using flow cytom-
etry (CD29, CD31, CD44, CD45, CD90, and CD105), adipogenic, osteo-
genic, and smooth muscle cell differentiation capacity as well as colony
formation capacity. Pooled nondiabetic ASCs (n = 3) of Passages 4–6
were used to prepare ASC conditioned medium (ASC‐CMe; containing
DMEM, 1%L‐Glut, and 1%P/S or RPMI 1%L‐Glut, and 1%P/S).Medium
was collected and filtered through a 0.22‐μm filter after 24 hr of culture.
ASC characterization was confirmed in accordance with the International
Federation of AdiposeTherapeutics and Science/International Society of
Cellular Therapy criteria (Bourin et al., 2013).2.6 | Generation of hydrogels incubated with
released factors by ASCs
NAM and DAM samples (n = 3) were digested with 2 mg/ml of porcine
pepsin (3,200 I.U. Sigma‐Aldrich) in 0.01 M of hydrochloric acid. One
milligram of porcine pepsin was used to digest 10 mg of lyophilized
acellular matrix. Acellular matrix was digested under constant stirring
for 6 hr at RT. Afterwards, the porcine pepsin was inactivated by pH
FIGURE 1 (a) Overview of the generation of ECM‐derived hydrogels incubated with concentrated ASC‐CMe. (b) Pregel solution prior to
warming to 37°C. (c) Hydrogel after gelation at 37°C. HCl: hydrogen chloride; NaOH: sodium hydroxide; ASC‐CMe: adipose stromal cell
conditioned medium; ECM: extracellular matrix; ASC: adipose stromal cell; PBS: phosphate‐buffered saline [Colour figure can be viewed at
wileyonlinelibrary.com]
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0.01 M of final concentration (Figure 1). Then ASC‐CMe was mixed
in order to allow released factors to bind to acellular matrix, and
finally, salt was added in order to allow for self‐assembly gelation.
To maintain the appropriate concentration of acellular matrix in hydro-
chloric acid to facilitate gelation, ASC‐CMe and PBS were added in a
concentrated form. ASC‐CMe was concentrated with the use of 3‐
kDa cut‐off Amicon® Ultra‐Centrifugal filters (Sigma‐Aldrich), respec-
tively, 20, 40, and 80 times. Twenty, 40, or 80 times concentrated
ASC‐CMe was added and carefully mixed to reach final dilutions of
respectively one time (ASC‐CMe1), two times (ASC‐CMe2), and four
times (ASC‐CMe4) concentrated ASC‐CMe (Figure 1). The released
factors bind to the acellular matrix pregel solutions at 4°C for 24 hr.
Next, the pregel solutions were brought to physiological conditions,
that is, 1× PBS by adding 20 times concentrated PBS. Finally, the
pregel solution was placed in an incubator to allow for self‐assembly
gelation for 1 hr at 37°C (Figure 1). Released factors from the incu-
bated hydrogels by ASC‐CMe1, ASC‐CMe2, and ASC‐CMe4 were har-
vested in serum‐free medium after 24 hr and stored at −80°C for
immunoassaying. The respective concentrated ASC‐CMe served as
input controls (2.8). Released factors from the incubated hydrogel by
ASC‐CMe1 were harvested in serum‐free medium after respectively
24, 48, and 96 hr and stored at −80°C for biological assays. For fibro-
blast migration and endothelial angiogenesis, the respective concen-
trated ASC‐CMe1 as well as DMEM serum‐free incubated hydrogels
harvested after 24 hr served as controls (2.9 and 2.11). For fibroblast
proliferation, the mean cell proliferation of fibroblast after using therespective concentrated ASC‐CMe was set at 100% (2.10). Moreover,
hydrogels were not cytotoxic (data not shown).2.7 | Characterization of viscoelastic relaxation
properties of the hydrogels
NAMandDAMhydrogels (n = 3) were formed in 0.8 mmof polydimeth-
ylsiloxane rings and placed on a glass slide derived from three different
pregel solutions per donor in duplicates (three technical replicates per
donor; Table 1). However, due to technical errors, single data were
obtained of pregel solution C of donor one and two. Then stress relax-
ation tests were performed on the NAM and DAM hydrogels with the
help of a low‐load compression tester in a nonhydrated environment
at RT (Korstgens, Flemming, Wingender, & Borchard, 2001). A stainless
steel plunger with a diameter of 0.25 cm was lowered towards the
hydrogels at 5 μm/s till the plunger came in contact with the gel (touch
load defined as 10 mg). This position was recorded, and similarly, the
position of the top of the glass slide was determined. Hydrogel thick-
ness was calculated with the difference of the two positions. Subse-
quently, the hydrogels were deformed by 20%, and the deformation
was held constant for 100 s, and the force responsewasmonitored over
time (Peterson, van der Mei, Sjollema, Busscher, & Sharma, 2013;
Sharma, Busscher, Terwee, Koopmans, & van Kooten, 2011). Force
was converted in stress by dividing with the area of cross section of
the plunger, whereas the deformation was converted in strain (defor-
mation/100). The slope of the straight‐line plot between stress and
TABLE 1 Nomenclature of nondiabetic acellular matrix and diabetic acellular matrix hydrogels derived from different pregel solutions
Donor 1 Donor 2 Donor 3
Pregel Solution A NAM1A/DAM1A NAM2A/DAM2A NAM3A/DAM3A
Pregel Solution B NAM1B/DAM1B NAM2B/DAM2B NAM3B/DAM3B
Pregel Solution C NAM1C/DAM1C NAM2C/DAM2C NAM3C/DAM3C
VAN DONGEN ET AL. 977strain during the deformation was taken as stiffness (E). Then the strain
was held constant at 0.2 for 100 s, and the stresswasmonitored. Because
hydrogels are viscoelastic in nature, the stress did not remain constant
but decreased (relaxed) with time. Total relaxation in 100 s was also
recorded. Relaxing stiffness (E(t)) was calculated by dividing relaxing
stress with constant strain. The relaxation was understood in terms of a
generalized Maxwell model by fitting the experimental data with the
equation using the optimization routine in the solver Add‐in of Microsoft
Excel 2007. Fitting startedwith oneMaxwell element, and graduallymore
elements were added till the decrease in chi‐squared (error function)
value became insignificant. Each Maxwell element was characterized by
the stiffness (Ei) and relaxation time constant (τi) for which it remained
active (Figure 5,b–d). The stiffness values were converted into relative
importance using the equation RI1 = 100*E1/(E1 + E2 … En).2.8 | Immunoassay of ECM hydrogels
NAM and DAM hydrogels (n = 3) were produced as previously
described for the immunoassay (two technical replicates; 2.6). Multi-
plex immunoassaying (Luminex, R&D systems) was used to measure
release of 11 representative ASC‐released proteinaceous factors
according to the manufacturer's protocol: VEGF‐A, angiopoetin‐1
(Ang‐1) and angiopoetin‐2 (Ang‐2), matrix metalloproteinase 1
(MMP‐1), tissue inhibitors of metalloproteinase 1 (TIMP‐1),
interleukin‐1β (IL‐1β), IL‐6, IL‐8/CXCL8, FGF‐1, hepatocyte growth
factor, and monocyte chemotactic protein 1 (MCP‐1/CCL2).2.9 | Fibroblast scratch assay
NAM and DAM hydrogels (n = 3) were produced as previously
described (three technical replicates; 2.6). PK84 fibroblasts were cul-
tured in DMEM (containing 10% FBS, 1% L‐Glut, and 1% P/S). After
confluency, PK84 fibroblasts were seeded into a 24‐well plate with a
cell density of 17,500 cells per square centimetre. Then cells were
serum starved overnight. The next day, a scratch was made with the
use of a 1,000 μl of pipette tip. Subsequently, cells were washed with
PBS three times, and all the different types of medium were applied.
Scratches were analysed after 9 hr.2.10 | Fibroblast proliferation assay
NAM and DAM hydrogels (n = 3) were produced as previously
described (three technical replicates; 2.6). PK84 fibroblasts were cul-
tured in DMEM (containing 10% FBS, 1% L‐Glut, and 1% P/S). After
confluency, fibroblasts were seeded into a 96‐well plate with a celldensity of 17,500 cells per square centimetre. After 24 hr, the differ-
ent types of medium were applied for 24 hr (2.6). After 24 hr, 20 μl
of MTT (5 mg/ml in PBS) was added and incubated for 3 hr at 37°C.
Next, medium was removed, and 100 μl of dimethyl sulfoxide was
added to dissolve the formazan crystals. Plates were read at 570 nm.
The fibroblast proliferation assay was repeated twice. Results were
expressed as percentage of cell proliferation compared with normal
culture medium (DMEM containing 10% FBS, 1% L‐Glut, and 1% P/S).
2.11 | Human umbilical vein endothelial cell
sprouting assay
NAM and DAM hydrogels (n = 3) were produced as previously described
(three technical replicates; 2.6). Instead of DMEM serum free, RPMI
serum‐free incubated hydrogels were used as a control (2.6). Human
umbilical cord vein endothelial cells (HUVECs) were isolated and cultured
in RPMI (containing 10% FBS, 1% L‐Glut, and 1% P/S). Micro Slide
Angiogenesis plates (Ibidi GmbH, Germany) were coated with 10 μl of
Matrigel™ (BD Bioscience, CA) and incubated at 37°C for 2 hr. HUVECs
were resuspended in all different types of medium. Sixty microlitres of
medium containing 10,000 cells was added per well. The slides were
incubated at 37°C for 6 hr. The sprouting networks that had formedwere
photographed with the use of an inverted light microscope (Leica
Microsystems, DM IL) and the number of loops was counted manually.
2.12 | Statistics
Scratch assay images were analysed using ImageJ, Version 1.4.3.67
(NIH). Descriptive statistics were used to evaluate the amount of DNA,
sGAG, stiffness and factor release profile of the hydrogels, scratch sur-
face area, fibroblast proliferation and the number of loops. Data were
expressed as mean with standard error of the mean, except for the con-
trols (serum‐free culturemedium andASC‐CMe1) and stiffness as well as
relaxation data of the hydrogels. Data of the controls as well as stiffness
and relaxation of the hydrogels were expressed as mean with standard
deviation. A one‐tailed t test was used to determine the statistical differ-
ence between the hydrogels and hydrogels versus controls with the use
of Graphpad, Version 7.0c (Graph Pad Software Inc., Los Angeles, CA).3 | RESULTS
3.1 | Fractionation and decellularization of adipose
tissue results in an acellular matrix
The fractionation of adipose tissue and its subsequent dece-
llularization process resulted in a completely acellular adipose matrix.
978 VAN DONGEN ET AL.Macroscopically, acellular matrix was white of colour, whereas one‐
time centrifuged adipose tissue and tSVF were yellow coloured
(Figure S1, left panels). Microscopically, the H&E staining together
with the absence of perilipin staining showed that the acellular matrix
contained neither adipocytes nor other remaining cells. In contrast, the
cell number in tSVF was higher as compared with one‐time centri-
fuged adipose tissue as observed by dense clusters of stromal cells
(Figure S1, second series of panels). In accordance with our previous
experience, fractionation of adipose tissue disrupted adipocytes,
whereas other cell types and ECM were preserved (van Dongen
et al., 2016). The absence of perilipin staining confirmed the disruption
of adipocytes (Figure S1, third series of panels). Furthermore,
Masson's trichrome staining demonstrated visibly higher amounts of
collagen (blue) per unit area in acellular matrix as compared with
one‐time centrifuged adipose tissue and tSVF (Figure S1, right panels).3.2 | Low amount of DNA left in acellular adipose
matrix
NAM and DAM samples contained negligible amounts of DNA with
12.83 ± 2.62 ng/mg per dry weight tissue for NAM and 60 ± 53.01 ng/
mg per dry weight tissue for DAM (p > 0.05; Figure S2A). The amount
of DNA in DAM is, however, higher than the amount of DNA in NAM.FIGURE 2 (a) The stiffness (kPa) for only NAM hydrogels (n = 3). DAM
stiffness of NAM hydrogels displayed as a function of time. All replicates
individual Maxwell elements as a function of relative time constants in sec
Maxwell element. NAM: nondiabetic acellular matrix; DAM: diabetic acellu
wileyonlinelibrary.com]All samples, except for one DAM sample, contained a lower amount of
DNA than 50 ng/mg per dry weight tissue, which is the standard for suc-
cessful decellularization. DAPI staining could not reveal nuclei in both
NAM as well as DAM as compared with the high number of nuclei after
the fractionation of adipose tissue procedure (Figure S2B).3.3 | No difference in sulphated glycosaminoglycans
There was no difference in amount of sGAGs in NAM and DAM sam-
ples with 0.93 ± 0.31 and 0.69 ± 0.31 μg sGAG per milligram dry
weight ECM respectively (p > 0.05; Figure S3). This was confirmed
by Alcian blue staining of control adipose tissue, tSVF, and as ECM
samples: Here, similar levels of staining were detected (Figure S3B).3.4 | Viscoelastic relaxation properties of NAM
hydrogels
Proteolytic treatment at RT of NAM and DAM liquified these matri-
ces, which formed stable hydrogels upon warming to 37°C, albeit of
relatively low mechanical strength. Viscoelastic relaxation properties
were determined for all NAM and DAM hydrogels; however, all
DAM hydrogels and one NAM gel collapsed during the measure-
ments and yielded no data. This indicates that structural differenceshydrogels collapsed and could not be evaluated. (b–d) Decrease in
of each donor (n = 3) are presented. (E) Relative importance of
onds for each replicate of all donors (n = 3). Each point represents one
lar matrix; kPa: kiloPascal [Colour figure can be viewed at
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ECM derived from nondiabetic donors. Average stiffness for all mea-
sured NAM hydrogels was relatively low with 1.81 ± 0.02 kPa
(Figure 2a). For each donor, three independent pregel solutions
derived from the same donor and ECM isolation were produced by
pepsin digestion (Table 1). Different pregel solutions showed a large
intradonor variation of stiffness (Figure 2a). The large intradonor var-
iation of stiffness warrants standardization of the gelation procedure.
The intradonor variation was also present in the relaxation properties
of the measured NAM hydrogels. Relaxation of stiffness showed a
fast decrease with the stiffness reaching zero within about 20 s
(Figure 2b–d). This was typical for most of the replicates, that is,
NAM1, −2 and −3 with each requiring 2 to 3 (Table 1 and Figure 2
e). The fast decrease shows that adipose tissue‐derived ECM
hydrogels are much more viscous than elastic. A more viscous gel is
less resistant to mechanical stress, that is, more prone to collapse
and therefore less suitable for clinical applications, which relate to
movement and friction such as wound healing. Stress relaxation as
a function of time was measured with the use of a Maxwell model
with each element in this model having a spring constant related to
the elastic part of the gel and a relaxation time constant representing
a viscous part of the gel. Two or three elements were sufficient and
the addition of more elements did not result in an improved quality
of the fit. The first element having a high relative importance and a
relaxation time constant of less than 1 s was most likely liquid that
was pushed out of the gel (Figure 2). The second element with a
relaxation time constant between 1 and 10 s, which was most likely
ECM. Interestingly, in some hydrogels, a third element was shown
with a relaxation time constant between 10 and 100 s. Hydrogels
that present a third element were also the hydrogels with the highest
stiffness and lowest relaxation.FIGURE 3 Statistical analyses of the concentration of released factors in
DAM samples (n = 3). ASC‐CMe: adipose derived stromal cell conditioned
matrix. One, two, and four displays the concentration factor of the factors
factors injected in NAM and DAM samples. The concentration of MMP1 e
Results are expressed as mean with standard error of the mean3.5 | Hydrogels bind and release ASC‐secreted
factors
Hydrogels derived from NAM and DAM samples mixed with concen-
trated CMe from cultured ASC bind released factors from ASC and
had released part of the measured factors after 24 hr. The concentra-
tions of factors were lower in the conditioned medium derived from
NAM and DAM samples in comparison with the three baseline con-
centrations of ASC‐CMe for MMP‐1, CXCL8, and IL‐6. The difference
in concentration of factors indicates that the release of bound factors
extends well beyond 24 hr. For Ang‐1, Ang‐2, and FGF‐1, a higher
concentration in conditioned medium derived from hydrogels as com-
pared with the baseline concentrations was found. This implies that
the hydrogels release more factors than initially were mixed in with
ASC‐CMe. This indicates that there were still factors present in ECM
after decellularization that were detectable by the immunoassay,
albeit that their bioactivity might not be retained after the harsh
decellularization procedures. There was no significant difference in
release pattern of any of the measured factors between nondiabetic
and diabetic‐derived hydrogels (p > 0.05; Figure 3). The concentra-
tions of IL‐1β and hepatocyte growth factor were below the detection
limit. In contrast, TIMP‐1 concentrations exceeded the maximal
detection limit and were therefore not plotted. These high concentra-
tions of TIMP‐1 indicate that most of the MMP‐1 released by ASC
and, therefore, released by the hydrogels is likely rendered inactive
by binding of TIMP‐1. Moreover, large interdonor variations in
releasing patterns were observed, especially in diabetic‐derived
hydrogels and mainly when two and four times concentrated ASC‐
CMe was mixed with the gels. This indicates a donor dependent
binding capacity limitation of specific factors such as VEGF‐A,
Ang‐1, Ang‐2, MMP‐1, and CCL2.baseline ASC‐CMe and conditioned medium derived from NAM and
medium; NAM: nondiabetic acellular matrix; DAM: diabetic acellular
in ASC‐CMe as well as the concentration of the hydrogel released
xceeded the upper limit of the assay in ASC‐CMe4 and was excluded.
980 VAN DONGEN ET AL.3.6 | Similar PK84 fibroblast migration when treated
with released factors by CMe‐loaded NAM and DAM
hydrogels
In comparison with serum‐free controls, conditioned medium from
ASC (ASC‐CMe1) promoted closure of damaged fibroblast monolayers
(Figure 4). Similarly, factors released from either NAM or DAM gels
promoted closure even after 96 hr of release (Figure 4). A similar
migration speed was detected between fibroblasts treated with fac-
tors from CMe‐loaded NAM and DAM hydrogels released after 24,
48, and 96 hr (p > 0.05; Figure 4). However, in comparison with
ASC‐CMe1, factors from CMe‐loaded DAM hydrogels released after
24 and 96 hr showed a smaller decrease in scratch surface area
(p < 0.05). For the NAM groups, all groups showed a larger decrease
in scratch surface area in comparison with controls, that is, serum‐free
culture medium (p < 0.05). For the DAM group, released factors from
CMe‐loaded hydrogels after 48 and 96 hr in comparison with serum‐
free controls showed a larger decrease in scratch surface area
(p < 0.05). This suggests that acellular adipose tissue matrix hydrogelsFIGURE 4 Statistical analyses of changes of the scratch surface area
(9 hr) compared with controls (serum‐free culture medium and ASC‐
CMe1) for conditionedmedium derived fromNAMandDAMhydrogels
(n = 3) with released factors after 24, 48, and 96 hr. NAM: nondiabetic
acellular matrix; DAM: diabetic acellular matrix; ASC‐CMe1: one time
concentrated (undiluted) adipose‐derived stromal cell conditioned
medium; FBS: fetal bovine serum. *Significant smaller scratch surface
area visible after the use of NAM 24hr, NAM 48hr, and NAM 96hr as
well as DAM 48hr and DAM 96hr in comparison with serum‐free
culture medium (p < 0.05). Moreover, the use of ASC‐CMe1 reduced
the scratch area in comparison with serum‐free culture medium
(p < 0.05). Significant smaller scratch area visible after the use of ASC‐
CMe1 in comparison with DAM 24hr and DAM 96hr (p < 0.05). Results
are expressed as mean with standard error of the mean for NAM and
DAMhydrogels. Results are expressed as meanwith standard deviation
for serum‐free culture medium and ASC‐CMe1released factors for at least 96 hr as observed by stimulated migration
of fibroblasts.3.7 | Proliferation of PK84 fibroblasts is increased
with released factors by CMe‐loaded DAM hydrogels
Factors released from both NAM and DAM gels promoted prolifera-
tion for 96 hr (Figure 5). Proliferation was higher in the DAM group
as compared with the NAM group with factors being released for 24
and 48 hr (p < 0.01 and p < 0.05, respectively; Figure 5). Furthermore,
the proliferation was increased in the NAM group with released fac-
tors after 24 versus 48 hr (p < 0.001) as well as after 24 versus
96 hr (p < 0.05) and was higher in the DAM group after 24 versus
96 hr (p < 0.01).3.8 | Similar sprouting ability of HUVEC when
treated with released factors by CMe‐loaded NAM and
DAM hydrogels
Sprouting of HUVEC was similar after treatment with factors released
from CMe‐loaded NAM hydrogels compared with DAM hydrogels
(p > 0.05; Figure 6). Moreover, a comparison of the total number of
loops between different times, that is, 24, 48, and 96 hr of released
factors was similar for both types of hydrogels (p > 0.05; Figure 6).
For the NAM groups, released factors from CMe‐loaded hydrogels
after 24 hr as well as 96 hr in comparison with serum‐free controlsFIGURE 5 Statistical analyses of fraction of proliferating cells
compared with ASC‐CMe for conditioned medium derived from
NAM and DAM hydrogels (n = 3) with released factors after 24, 48,
and 96 hr. NAM: nondiabetic acellular matrix; DAM: diabetic acellular
matrix; ASC‐CMe1: one time concentrated (undiluted) adipose derived
stromal cell conditioned medium. *Significantly more proliferation
occurred between NAM 24hr versus NAM 96hr and NAM 48hr versus
DAM 48hr (p < 0.05). **Significantly more proliferation occurred
between NAM 24hr versus DAM 24hr and DAM 24hr versus DAM
96hr (p < 0.01). ***Significantly more proliferation occurred between
NAM 24hr versus NAM 48hr (p < 0.001). Results are expressed as
mean with standard error of the mean for NAM and DAM hydrogels
FIGURE 6 Statistical analyses of the number of loops of the 6‐hr
sprouting assay compared with controls (serum‐free culture medium
and ASC‐CMe1) for conditioned medium derived from NAM and
DAM hydrogels (n=3) with released factors after 24, 48, and 96 hr.
NAM: nondiabetic acellular matrix; DAM: diabetic acellular matrix;
ASC‐CMe1: one time concentrated (undiluted) adipose‐derived
stromal cell conditioned medium; FBS: fetal bovine serum.
*Significantly more loops visible after the use of NAM24h, NAM96h,
DAM24h as well as DAM48h in comparison with serum free culture
medium (p < 0.05). **Significantly more loops visible after the use of
ASC‐CMe1 in comparison with serum free culture medium (p < 0.01).
Results are expressed as mean with standard error of the mean for
NAM and DAM hydrogels. Results are expressed as mean with
standard deviation for serum‐free culture medium and ASC‐CMe1
VAN DONGEN ET AL. 981showed more loops (p < 0.05). Unexpectedly, no significant difference
in the group of released factors from CMe‐loaded NAM hydrogels
after 48 hr compared with serum‐free medium was found. This is
probably caused by large interdonor variation, because the mean num-
ber of loops is higher in the group of released factors from CMe‐
loaded NAM hydrogels after 48 hr. Moreover, these results indicate
that CMe‐loaded hydrogels function as a controlled slow release scaf-
fold of factors that stimulate sprouting even after 96 hr. For the DAM
group, released factors from CMe‐loaded hydrogels after 24 hr as well
as 48 hr in comparison with serum‐free culture medium showed more
loops (p < 0.05). The mean number of loops for ASC‐CMe1 was com-
parable with the mean number of loops for the NAM and DAM
hydrogels (p > 0.05).4 | DISCUSSION
In this study, we demonstrated that acellular ECM hydrogels from
decellularized adipose tissue incubated with factors released by ASC
functioned as a controlled slow release scaffold. These ECM hydrogels
bound a series of different factors, which were released in an incre-
mental fashion for at least 96 hr and maintained their biologicalactivity. These ECM hydrogels showed to be noncytotoxic as well.
Diabetic origin of the hydrogels did not substantially affect the biolog-
ical activity nor concentrations of the released factors; small differ-
ences in kinetics of biological assays were seen for unknown
reasons. Yet diabetic ECM‐derived hydrogels had a too low mechani-
cal strength and are therefore less suitable for clinical applications.
Thus, CMe‐incubated nondiabetic‐derived hydrogels seems to be a
promising new treatment modality to augment wound healing.
The released factors by ASC‐CMe‐loaded ECM hydrogels stimu-
lated several important wound healing‐related processes including an
increased fibroblast proliferation and migration as well as sprouting
by HUVECs, that is, surrogate angiogenesis. Diabetic origin did not
affect either of these processes, except that cell proliferation of fibro-
blasts was reduced 24 and 48 hr after release of factors by nondia-
betic hydrogels in comparison with diabetic hydrogels. Yet the
immunoassay showed similar concentrations of factors released by
both types of hydrogels. This suggests that the releasing pattern of
some factors might be different when released by hydrogels of dia-
betic origin, for example, a faster release. A faster release of factors
results, however, in a faster depletion of factors in ASC‐CMe‐loaded
hydrogels and thus a shorter time to promote wound healing. More-
over, factors will be actively subtracted from the hydrogel in vivo
instead of accumulation of factors until a concentration balance is
reached between inside and outside the hydrogel. Additionally, fibro-
blast cell proliferation increased over time after using released factors
in an incremental fashion up to 96 hr.
Wound healing comprises different processes that show spatiotem-
poral overlapping phases with different processes of which some, for
example, angiogenesis, fibroblast proliferation, and migration are inves-
tigated in this study. Our results suggest that released factors from
ASC‐CMe‐loaded hydrogels influence both the course and kinetics of
these phases. These human ECM‐derived hydrogels allow the allogenic
administration because both factors released by ASC as well as ECM
will not induce an adverse immune reaction. In fact, ECM components
are evolutionary highly conserved, which warrants the use of animal‐
derived ECM hydrogels, for example, pig dermal ECM hydrogels. The
potential therapeutic value of this “one‐donor‐for‐all” treatmentmodal-
ity for wound healing purposes is based on biological properties as well
as physical properties. Biologically, a plethora of factors can be bound
and released by ECM. In this way, wound healing can be enhanced by
influencing processes like angiogenesis, apoptosis, chemoattraction of
immune cells, and support of local mesenchymal or progenitor cells
(Barrientos, Stojadinovic, Golinko, Brem, & Tomic‐Canic, 2008). Angio-
genesis is enhanced by VEGF and FGF‐1, especially under hypoxia
(Rehman et al., 2004). ASC‐CMe, which contains VEGF and FGF‐1,
increases endothelial proliferation and suppresses cell apoptosis under
hypoxia. Both proliferation of endothelial cells and survival are impor-
tant mechanisms in wound healing (Chavakis & Dimmeler, 2002).
Additionally, VEGF also functions as a chemoattractant for local pro-
genitor cells as well as macrophages (Chen, Tredget, Wu, & Wu,
2008). Macrophages, attracted by chemokines such as ASC‐released
CXCL8, play an important role in the different phases of wound healing
(Weidenbusch & Anders, 2012). During the inflammation phase,
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proliferation phase, epithelial proliferation is enhanced by activated
macrophages (Weidenbusch & Anders, 2012). Furthermore, re‐
epithelialization by keratinocyte proliferation andmigration is also stim-
ulated by CXCL8, which was bound and released by our ECM hydrogels
(Barrientos et al., 2008). Besides increased re‐epithelialization, CXCL8
is also responsible for the attraction of leukocytes, which results in an
increased phagocytosis during the inflammation phase (Rennekampff
et al., 2000). The presence of leukocytes and macrophages is prolonged
by the presence of MCP1, as MCP1 is a chemoattractant for macro-
phages, mast cells, and T‐cells (Barrientos et al., 2008). A prolonged
presence of leukocytes and macrophages results in a sustained proin-
flammatory state of the wound (Wetzler, Kampfer, Stallmeyer,
Pfeilschifter, & Frank, 2000). After the inflammation phase, a decrease
in inflammatory signalling is needed to induce formation of granulation
tissue and subsequently re‐epithelialization. In vitro and in vivo experi-
ments have shown that GAG‐binding sites are able to modulate chemo-
kine gradients of MCP1 and IL8 by subduction in excisional wounds
(Lohmann et al., 2017). In this way, ECM hydrogels incubated with
ASC‐CMe can modulate inflammation in wounds by both releasing
and attracting growth factors and chemokines.
Besides the biological function of our studied hydrogel, its physical
properties are also of crucial importance. Physical properties of the
hydrogel such as stiffness affect ASC and other cells present in the sur-
rounding tissue of the wound. Low stiffness hydrogels promote
adipogenic differentiation of native ASC, whereas stiff hydrogels pro-
mote their osteogenic differentiation (Schellenberg et al., 2014). The
soft nondiabetic hydrogels support adipogenic differentiation of host
tissues ASC; however, the bound factors together with the stiffness
of the hydrogel dictate final cell fate (Schellenberg et al., 2014). A soft
hydrogel is also easier infiltrated by host cells like ASC and endothelial
cells than stiff hydrogels. In this way, both ASC and endothelial cells
can stimulate angiogenesis inside the hydrogel, which might result in
increased wound healing rates (Terlizzi, Kolibabka, Burgess, Hammes,
& Harmsen, 2017). It remains to be determined whether the stability
and longevity of these hydrogels supports cells' maintenance, migra-
tion, and differentiation. Also, it is unknown if the hydrogels with a
low stability can resist all mechanical stress during application of the
hydrogel in vivo. The enzymatic degradation to convert complex ECM
structures into gels has inspired physical chemists to compile prediction
models (Abete, de Candia, Lairez, & Coniglio, 2004; Jones, Liang, Lin,
Jiao, & Sun, 2014). However, from a pragmatic point of view, produc-
tion of (pre)gels from freeze‐dried, fine‐powdered ECMs requires care-
ful standardization of enzyme treatment. These should consider, for
example, the disease background of the ECM, because our results show
differences between diabetic and nondiabetic ECM hydrogels, that is,
gels of diabetic origin collapse. Regarding future application, diabetic
hydrogels will not suffice due to their limited physical strength. As a
matter of fact, viscoelasticitymeasurements proved impossible because
diabetic hydrogels collapsed readily. This indicates the presence of
structural differences in matrix between nondiabetic and diabetic
donors. This difference could be caused by accumulation of AGEs in
ECM, which results in more cross links between proteins and thereforea high stability of the ECM proteins (Voziyan et al., 2014). The major
component of ECM is Collagen Type I, and glucose‐based AGEs may
cause a high level of intramolecular Lys‐Arg and Lys‐Lys cross links that
increase the molecule's stiffness (Gautieri, Redaelli, Buehler, &
Vesentini, 2014). The glycation and cross linkingmasks potential pepsin
digestion sites and thus yields different, likely larger, fragments upon
pepsin treatment. As it appeared, these fragments did not yield
hydrogels from diabetic ECM. Instead of adipose tissue, other sources
of matrices with a higher stiffness might also suit to enhance wound
healing. Our recent data show that ECM hydrogels from heart or aorta
tissue have a higher viscoelasticity (to be published elsewhere).
To date, most studies that evaluate decellularized adipose tissue
focus on tissue engineering of a new subcutaneous fat layer rather
than its use to augment wound healing (Choi et al., 2010; Choi et al.,
2011; Debels et al., 2017; Flynn, 2010; Uriel et al., 2008). Moreover,
all these studies used adipose matrix‐derived hydrogels without incu-
bation of paracrine factors. Without the use of additional paracrine
factors and cytokines, the soft adipose matrix will most likely only
regenerate a soft subcutaneous fat layer. Yet, to regenerate a dermal
layer for wound healing purposes, the addition of factors released by
ASC is warranted. A combination of factors released by ASC and a soft
adipose matrix‐derived hydrogel might, therefore, be an ideal treat-
ment modality for full thickness wounds.
Both types of gel released functional factors over a longer time.
However, a large interdonor variation remains regardless the origin of
the ECM. The interdonor variation might be caused by the fact that
ECMderived fromdifferent donorswith different “pack years” of diabe-
tes. In this way, the amount of AGEs accumulation is different between
donors. Moreover, liposuction procedures are performed on lean
patients and patients with obesity. However, obese patients frequently
acquire DM type 2 with high levels of glucose prior to diagnosis. It is
feasible that ECM derived from nondiabetic donors was exposed to
high levels of glucose already. Finally, the medical history of the anony-
mous donationswas unknown.We cannot exclude the influence of age,
gender, BMI, and other confounding factors on the donor variation (Di
Taranto et al., 2015; Dos‐Anjos Vilaboa, Navarro‐Palou, & Llull, 2014;
Engels et al., 2013; Maredziak, Marycz, Tomaszewski, Kornicka, &
Henry, 2016). This warrant to standardize the generation of factor‐
loaded ECM hydrogels with regard to both producing ASC and to
source of the ECM. The low yield of adipose‐derived ECM (w/v base)
hampers clinical application of adipose tissue‐derived hydrogels.
In summary, this study shows that several important wound
healing‐related processes, that is, angiogenesis, fibroblast migration,
and proliferation are stimulated by a sustained release of growth fac-
tors from ECM‐derived hydrogels. Therefore, the use adipose tissue
ECM‐derived hydrogels incubated with released factors from ASCs
become a promising new treatment modality to augment disturbed
dermal wound healing, for example, diabetic ulcers. Animal studies
are warranted as an essential prelude to clinical trials.FUNDING INFORMATION
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Fig. S1 Light micrographs of hematoxylin & eosin staining, perilipin A
staining and Masson's trichrome staining of respectively centrifuged
adipose tissue, tSVF and extracellular matrix. tSVF = tissue stromal
vascular fraction.
Fig. S2 (A) Statistical analyses of DNA contents per dry weight ECM
(ng/mg) of NAM and DAM samples (n = 3). (B) Immunofluorescent
microscope photographs of DAPI staining. ECM = extracellular matrix,
NAM = non‐diabetic acellular matrix, DAM = diabetic acellular matrix,
AT = adipose tissue, tSVF = tissue stromal vascular fraction, NS = non‐
significant. Results are expressed as mean with standard error of the
mean.Fig. S3 (A) Statistical analyses of sGAG contents per dry weight ECM
(μg/mg) of NAM and DAM samples (n = 3). (B) Light microscope pho-
tographs of alcian blue staining. sGAG = sulphated glycosaminoglycan,
ECM = extracellular matrix, NAM = non‐diabetic acellular matrix,
DAM = diabetic acellular matrix, AT = adipose tissue, tSVF = tissue
stromal vascular fraction, NS = non‐significant. Results are expressed
as mean with standard error of the mean.
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